The non-pfjptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs
- 28 March 1997
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 60 (18), 1553-1561
- https://doi.org/10.1016/s0024-3205(97)00121-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- 3-Aryl-1,2-diacetamidopropane Derivatives as Novel and Potent NK-1 Receptor AntagonistsJournal of Medicinal Chemistry, 1996
- Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of ratsNeuropharmacology, 1995
- Blockade by oral or parenteral RPR 100893 (a non‐peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea‐pig dura mater and conjunctivaBritish Journal of Pharmacology, 1994
- Inhibition of neurogenic inflammation in the meninges by a non-peptide NK1 receptor antagonist, RP 67580European Journal of Pharmacology, 1993
- The non‐peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of ratsBritish Journal of Pharmacology, 1993
- Capillary permeability induced by intravenous neurokininsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1989
- Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brainJournal of Neuroscience, 1987
- Studies on the trigeminal antidromic vasodilatation and plasma extravasation in the rat.The Journal of Physiology, 1984
- Perivascular Meningeal Projections from Cat Trigeminal Ganglia: Possible Pathway for Vascular Headaches in ManScience, 1981
- NEUROTRANSMITTERS AND THE FIFTH CRANIAL NERVE: IS THERE A RELATION TO THE HEADACHE PHASE OF MIGRAINE?The Lancet, 1979